Vortioxetine versus sertraline in metabolic control, distress and depression in Mexican patients with type 2 diabetes

MLA

Antonia Pérez-Mandujano, et al. “Vortioxetine versus Sertraline in Metabolic Control, Distress and Depression in Mexican Patients with Type 2 Diabetes.” Annals of Translational Medicine, vol. 7, Nov. 2019, p. 656. EBSCOhost, https://doi.org/10.21037/atm.2019.10.56.

APA

Antonia Pérez-Mandujano, Thelma Beatriz González-Castro, Iris Rubí Ramírez-González, Jorge L. Ble-Castillo, Ana Fresán, Mario Villar-Soto, Ester Rodríguez-Sánchez, Samuel Suarez-Mendez, Carlos Alfonso Tovilla-Zárate, Isela Esther Juárez-Rojop, María Lilia López-Narváez, & Esteban Martínez-Villaseñor. (2019). Vortioxetine versus sertraline in metabolic control, distress and depression in Mexican patients with type 2 diabetes. Annals of Translational Medicine, 7, 656. https://doi.org/10.21037/atm.2019.10.56

Chicago

Antonia Pérez-Mandujano, Thelma Beatriz González-Castro, Iris Rubí Ramírez-González, Jorge L. Ble-Castillo, Ana Fresán, Mario Villar-Soto, Ester Rodríguez-Sánchez, et al. 2019. “Vortioxetine versus Sertraline in Metabolic Control, Distress and Depression in Mexican Patients with Type 2 Diabetes.” Annals of Translational Medicine 7 (November): 656. doi:10.21037/atm.2019.10.56.